USA: Livingston, NJ Europe: Barcelona, Spain Oxford, UK Hamburg, Germany Asia: Kobe, Japan South America: Lima, Peru VALIDATION OF MICROARRAY CGH FOR PGD BY FISH REANALYSIS Santiago Munné, Cristina Gutierrez-Mateo, Jorge Sanchez- Garcia, Kelly Ketterson, Renata Prates, Daniel Kenigsberg Reprogenetics, Livingston, NJ; Long Island IVF, Melville, NY
presentation on the validation studies of array CGH validation for its use in PGD for the detection of ALL chromosome aneuploidies.
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
USA: Livingston, NJ Europe: Barcelona, Spain Oxford, UK Hamburg, Germany
Asia: Kobe, Japan
South America: Lima, Peru
VALIDATION OF MICROARRAY CGH FOR PGD BY FISH REANALYSIS
Santiago Munné, Cristina Gutierrez-Mateo, Jorge Sanchez-Garcia, Kelly Ketterson, Renata
Prates, Daniel Kenigsberg
Reprogenetics, Livingston, NJ; Long Island IVF, Melville, NY
• ConversionConversion
• Sequential FISH with 24 probesSequential FISH with 24 probes
control : control : 113113 37.137.1 1.2 1.2 2.7 2.7 46%46% p<0.0001 p<0.0001
Schoolcraft et al. (in press)Schoolcraft et al. (in press)
CGH on blastocyst biopsies:CGH on blastocyst biopsies:Preliminary clinical resultsPreliminary clinical results
Validation of aCGHValidation of aCGH
CGH-based DNA CGH-based DNA Microarray (aCGH)Microarray (aCGH)
Test DNA
Normal DNA
2700 probesSame band resolution as karyotype
aCGH advantagesaCGH advantages
• Results in Results in 2424 hours; allows for PB or day 3 biopsy hours; allows for PB or day 3 biopsy
• Parental DNA Parental DNA notnot required: ad hoc decisions possible required: ad hoc decisions possible
• Detects trisomy originating from mitotic errors or MII Detects trisomy originating from mitotic errors or MII meiotic errors without crossing-over (SNP array may not).meiotic errors without crossing-over (SNP array may not).
46,XX
47,XX+2
44,XX-9-17
46,XY-10 +16
aCGH detected aCGH detected 50%50% more abnormalities than FISH-12 and more abnormalities than FISH-12 and 20%20% more abnormal embryos (Colls et al. 2009)more abnormal embryos (Colls et al. 2009)
Detection of abnormalities: Detection of abnormalities: aCGH vs FISH-12aCGH vs FISH-12
Detectable by FISH
aCGH validation: no resultsaCGH validation: no results
• OldOld11 array: array:Embryos undiagnosed (biopsy day 5): Embryos undiagnosed (biopsy day 5): 50% (n=30)50% (n=30)
• NewNew22 array, old array, old33 amplification: amplification:Embryos undiagnosed (biopsy day 3): Embryos undiagnosed (biopsy day 3): 12% (n=163)12% (n=163)
• NewNew22 array, New array, New44 amplification: amplification:Embryos undiagnosed (biopsy day 3): Embryos undiagnosed (biopsy day 3): 0% (n=73)0% (n=73)Embryos undiagnosed (biopsy day 5): Embryos undiagnosed (biopsy day 5): 0% (n=16)0% (n=16)
• Validation method: Reanalysis of the rest of the embryo Validation method: Reanalysis of the rest of the embryo by FISH with 12 chromosomes plus those found abnormal by FISH with 12 chromosomes plus those found abnormal by aCGHby aCGH
• Error rate (biopsy day 3): Error rate (biopsy day 3): 6% 6% (same as expected by (same as expected by mosaicism), biopsy d5 still n/amosaicism), biopsy d5 still n/a
aCGH results on day 3: validation dataaCGH results on day 3: validation data
Cells from the same embryo:Cells from the same embryo:
- Blastocyst biopsy + CGH + vitrification shows very Blastocyst biopsy + CGH + vitrification shows very high implantation rates (72%, av. Age 38).high implantation rates (72%, av. Age 38).
- Array CGH most likely will produce similar benefits in Array CGH most likely will produce similar benefits in that combinationthat combination
- Array CGH and day 3 biopsy (day 5 results) will detect Array CGH and day 3 biopsy (day 5 results) will detect 20% more abnormal embryos than FISH-12 probes 20% more abnormal embryos than FISH-12 probes
- Additional vitirifcation step may still be advantageousAdditional vitirifcation step may still be advantageous
91,070 embryos analyzed by FISH with 9-12 probes:91,070 embryos analyzed by FISH with 9-12 probes:
Polyploid or haploid:Polyploid or haploid: 7.7%7.7%- plus aneuploidy:- plus aneuploidy: 5.9% (detectable by aCGH)5.9% (detectable by aCGH)
- no other abnormalities:- no other abnormalities: 1.8% (not detectable by aCGH)1.8% (not detectable by aCGH)- Arrested or dysmorphic:- Arrested or dysmorphic: 1.6% (unlikely replaced)1.6% (unlikely replaced)- Good morphology:- Good morphology: 0.2%0.2% (risk of misdiagnosis) (risk of misdiagnosis)
SNP arrays may not detect mitotic trisomiesSNP arrays may not detect mitotic trisomies
91,070 embryos analyzed by FISH with 9-12 probes:91,070 embryos analyzed by FISH with 9-12 probes:
Complex abnormal mosaics:Complex abnormal mosaics: 26,624 (29%)26,624 (29%)- with only trisomies:- with only trisomies: 4,029 4,029
- of mitotic origin (76.2%)*:- of mitotic origin (76.2%)*: 3,070 3,070 (3.4% potential error)(3.4% potential error)